Evogene Ltd.
EVGN
$0.97
-$0.0255-2.56%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 10.36% | 34.62% | 34.62% |
| Total Depreciation and Amortization | -- | -- | 1.24% | 3.97% | 3.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -92.18% | -60.28% | -60.28% |
| Change in Net Operating Assets | -- | -- | 48.12% | 64.97% | 64.97% |
| Cash from Operations | -- | -- | 8.87% | 39.30% | 39.30% |
| Capital Expenditure | -- | -- | 32.96% | 27.11% | 27.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -126.16% | -120.79% | -120.79% |
| Cash from Investing | -- | -- | -134.19% | -127.97% | -127.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 10.01% | -67.09% | -67.09% |
| Issuance of Common Stock | -- | -- | 30,075.00% | 56,066.67% | 56,066.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 4.16% | 4.85% | 4.85% |
| Cash from Financing | -- | -- | 94.28% | 86.98% | 86.98% |
| Foreign Exchange rate Adjustments | -- | -- | 89.27% | 89.72% | 89.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -145.38% | 21.55% | 21.55% |